Rigel Pharmaceuticals | Attività Correnti





Attività Correnti Cambiamento Data
Agenus USD 133.95M 120.61M 2025-09
Amgen USD 29.06B 1.17B 2025-12
Anika Therapeutics USD 101.59M 2.27M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Celldex Therapeutics USD 604.34M 44.06M 2025-09
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Eli Lilly USD 62.07B 12.22B 2025-09
Halozyme Therapeutics USD 1.33B 206.08M 2025-09
Heron Therapeutics USD 229.4M 18.48M 2025-09
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Ligand Pharmaceuticals USD 753.92M 400.98M 2025-09
MacroGenics USD 232.09M 27.15M 2025-09
Neurocrine Biosciences USD 2.16B 409.5M 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Veracyte USD 449.22M 34.54M 2025-09


Rigel Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.